Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence

被引:1
|
作者
Won, Ho-Ryun [1 ,2 ]
Kim, Min Gyu [1 ]
Kim, Min Soo [1 ]
Chang, Jae Won [1 ,3 ]
Koo, Bon Seok [1 ,3 ]
机构
[1] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea
[2] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Sejong Hosp, Sejong, South Korea
[3] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
thyroid cancer; papillary thyroid microcarcinoma; active surveillance; recurrence; clinical factor; BRAF MUTATION; CANCER; ASSOCIATION; CARCINOMA;
D O I
10.1530/ETJ-23-0195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Active surveillance (AS) has been suggested as a management option for low-risk papillary thyroid microcarcinoma (PTMC). However, the currently proposed selection criteria for AS application do not consider various clinical factors. The purpose of this study was to analyze clinical factors related to recurrence that could be confirmed preoperatively in patients who underwent surgery for PTMC and to identify factors worth considering when deciding whether to apply AS. Materials and methods: Data were collected from patients with PTMC who underwent surgical treatment at Chungnam National University Hospital. A retrospective cohort was established according to the presence or absence of recurrence during the follow-up period. In total, 2717 patients were enrolled, of whom 60 experienced recurrence. Various clinical factors that could be identified before surgery were analyzed. Results: The relationship between various clinical factors that could be confirmed preoperatively and recurrence was confirmed through Cox regression analysis and Kaplan-Meier curve analysis. BRAF mutation and the tall cell variant were significantly more common in patients with recurrence. In patients aged 55 years or older, the risk of recurrence was lower than in younger patients, while the recurrence-free survival (RFS) rate was higher. Conclusion: When choosing between surgical treatment or AS in PTMC patients, additional consideration of the patient's clinical factors, such as age and BRAF mutation status, may be required in addition to the existing criteria.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
    Luo, Y.
    Zhao, Y.
    Chen, K.
    Shen, J.
    Shi, J.
    Lu, S.
    Lei, J.
    Li, Z.
    Luo, D.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (02) : 227 - 236
  • [32] Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
    Y. Luo
    Y. Zhao
    K. Chen
    J. Shen
    J. Shi
    S. Lu
    J. Lei
    Z. Li
    D. Luo
    Journal of Endocrinological Investigation, 2019, 42 : 227 - 236
  • [33] Is advocacy for active surveillance over definitive intervention in papillary thyroid microcarcinoma applicable to European patients?
    Dionigi, Gianlorenzo
    GLAND SURGERY, 2018, 7 (02) : 242 - 243
  • [34] Nodal metastasis and recurrence in papillary thyroid microcarcinoma
    Pisanu, Adolfo
    Saba, Alessandra
    Podda, Mauro
    Reccia, Isabella
    Uccheddu, Alessandro
    ENDOCRINE, 2015, 48 (02) : 575 - 581
  • [35] Nodal metastasis and recurrence in papillary thyroid microcarcinoma
    Adolfo Pisanu
    Alessandra Saba
    Mauro Podda
    Isabella Reccia
    Alessandro Uccheddu
    Endocrine, 2015, 48 : 575 - 581
  • [36] Prognostic parameters for recurrence of papillary thyroid microcarcinoma
    Tae Yong Kim
    Suck Joon Hong
    Jung Min Kim
    Won Gu Kim
    Gyungyub Gong
    Jin Sook Ryu
    Won Bae Kim
    Sung-Cheol Yun
    Young Kee Shong
    BMC Cancer, 8
  • [37] Prognostic parameters for recurrence of papillary thyroid microcarcinoma
    Kim, Tae Yong
    Hong, Suck Joon
    Kim, Jung Min
    Kim, Won Gu
    Gong, Gyungyub
    Ryu, Jin Sook
    Kim, Won Bae
    Yun, Sung-Cheol
    Shong, Young Kee
    BMC CANCER, 2008, 8 (1)
  • [38] Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?
    Liu, Qi
    Song, Mingyuan
    Zhang, Hao
    JOURNAL OF CANCER, 2024, 15 (04): : 1009 - 1020
  • [39] Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy
    Sae Rom Chung
    Jung Hwan Baek
    Young Jun Choi
    Jeong Hyun Lee
    Current Oncology Reports, 2022, 24 : 1045 - 1052
  • [40] Active Surveillance for Papillary Thyroid Microcarcinoma in a Population with Restrictive Diagnostic Workup Strategies
    Loncar, Ivona
    van Dijk, Sam P. J.
    Metman, Madelon J. H.
    Lin, Jia Feng
    Kruijff, Schelto
    Peeters, Robin P.
    Engelsman, Anton F.
    van Ginhoven, Tessa M.
    THYROID, 2021, 31 (08) : 1219 - 1225